Skip to main content

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Ana Alvarez Guaita

Institutions of which they are part

Postdoctoral researcher
Diabetes and Metabolism
Vall Hebron Institut de Recerca

Related news

The work represents a paradigm shift in the clinical approach to this chronic, multifactorial disease, based on the clinical context of each patient and not only on weight loss.

The results of a phase 3 clinical trial show that orforglipron reduces body weight by an average of 11% and improves cardiovascular risk factors.

Dr. Maria Llorián-Salvador, from the Diabetes and Metabolism Research Group at VHIR, is leading this project to identify new therapies for this inherited disease that causes progressive vision loss.

Related professionals

Ana Laura Cazurro Gutierrez

Ana Laura Cazurro Gutierrez

Predoctoral researcher
Therapeutics and Innovations in Neuropediatrics and other paediatric rare diseases
Read more
Raul Aguilar Lopez

Raul Aguilar Lopez

Research technician
Cardiovascular Diseases
Read more
Estevo Santamarina Pérez

Estevo Santamarina Pérez

Head of group
Research Group on Status Epilepticus and Acute Seizures
Read more
Merce  Ferrerons  Sanchez

Merce Ferrerons Sanchez

Main researcher
Multidisciplinary Nursing Research Group
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.